QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Online Supporting Material Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shen, P. Articles by Yong, E. L. Search for Related Content PubMed PubMed Citation Articles by Shen, P. Articles by Yong, E. L.

---

Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions

Differential Effects of Isoflavones, from Astragalus Membranaceus and Pueraria Thomsonii, on the Activation of PPAR, PPAR, and Adipocyte Differentiation In Vitro^1–3,

P. Shen^*, M. H. Liu^*, T. Y. Ng^*, Y. H. Chan and E. L. Yong^*,4

^* Department of Obstetrics and Gynecology, and Department of Biostatistics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074

⁴ To whom correspondence should be addressed. E-mail: obgyel{at}nus.edu.sg.

Compounds that target the peroxisome proliferator-activated receptors PPAR and PPAR are used to correct dyslipidemia and to restore glycemic balance, respectively. Because the majority of diabetic patients suffer from atherogenic lipid abnormalities, in addition to insulin resistance, ligands are required that can activate both PPAR and PPAR. In this study, we used chimeric PPAR/ reporter-gene bioassays to screen herbal extracts with purported antidiabetic properties. Extracts of Astragalus membranaceus and Pueraria thomsonii significantly activated PPAR and PPAR. Bioassay-guided fractionation resulted in the isolation of the isoflavones, formononetin, and calycosin from Astragalus membranaceus, and daidzein from Pueraria thomsonii as the PPAR-activating compounds. We investigated the effects of these and 2 common isoflavones, genistein and biochanin A, using chimeric and full-length PPAR constructs in vitro. Biochanin A and formononectin were potent activators of both PPAR receptors (EC₅₀ = 1–4 µmol/L) with PPAR/PPAR activity ratios of 1:3 in the chimeric and almost 1:1 in the full-length assay, comparable to those observed for synthetic dual PPAR-activating compounds under pharmaceutical development. There was a subtle hierarchy of PPAR/ activities, indicating that biochanin A, formononetin, and genistein were more potent than calycosin and daidzein in chimeric as well as full-length receptor assays. At low doses, only biochanin A and formononetin, but not genistein, calycosin, or daidzein, activated PPAR-driven reporter-gene activity and induced differentiation of 3T3-L1 preadipocytes. Our data suggest the potential value of isoflavones, especially biochanin A and their parent botanicals, as antidiabetic agents and for use in regulating lipid metabolism.

KEY WORDS: • PPAR • PPAR • isoflavones • adipocyte differentiation

This article has been cited by other articles:

				L. M. Alleva, C. Cai, and I. A. Clark Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza Evid. Based Complement. Altern. Med., September 24, 2009; (2009) nep152v1. [Abstract] [Full Text] [PDF]

				A. Orgaard and L. Jensen The Effects of Soy Isoflavones on Obesity Experimental Biology and Medicine, September 1, 2008; 233(9): 1066 - 1080. [Abstract] [Full Text] [PDF]

				M. H. Liu, J. Li, P. Shen, B. Husna, E. S. Tai, and E. L. Yong A Natural Polymorphism in Peroxisome Proliferator-Activated Receptor-{alpha} Hinge Region Attenuates Transcription due to Defective Release of Nuclear Receptor Corepressor from Chromatin Mol. Endocrinol., May 1, 2008; 22(5): 1078 - 1092. [Abstract] [Full Text] [PDF]